Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 11 records, 2 pages
Search For: Short-acting Recombinant Human Erythropoietin
Global Short-acting Recombinant Human Erythropoietin Supply, Demand and Key Producers, 2024-2030
06 Mar 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin
The global Short-acting Recombinant Human Erythropoietin market size is expected to reach $ 14120 million by 2030, rising at a market growth of 5.9% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
19 Jan 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2024-2030
06 Mar 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Drugs
The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
19 Jan 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Drugs
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14300 million by 2030 with a CAGR of 6.1% during review period.
USD3480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Injections Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Injections
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Injections market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Injections Supply, Demand and Key Producers, 2023-2029
02 Jan 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Injections
The global Short-acting Recombinant Human Erythropoietin Injections market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Injections Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
02 Jan 2024
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Injections
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Injections market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Supply, Demand and Key Producers, 2023-2029
26 Sep 2023
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin
The global Short-acting Recombinant Human Erythropoietin market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
26 Sep 2023
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
Global Short-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2023-2029
21 Oct 2023
Pharma & Healthcare
Short-acting Recombinant Human Erythropoietin Drugs
The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Short-acting Recombinant Human Erythropoietin
Total: 11 records, 2 pages
The global Short-acting Recombinant Human Erythropoietin market size is expected to reach $ 14120 million by 2030, rising at a market growth of 5.9% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14300 million by 2030 with a CAGR of 6.1% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Injections market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
The global Short-acting Recombinant Human Erythropoietin Injections market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin Injections market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
The global Short-acting Recombinant Human Erythropoietin market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Short-acting Recombinant Human Erythropoietin market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.
USD3480.00
Add To Cart
The global Short-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 14300 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>